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1. Introduction 
A FEBS Advanced Course (No. 43) was held from 
September 21-23, 1976 at The Middlesex Hospital 
Medical School under this title. Since the Course was 
concerned with a new and original aspect of bioche- 
mistry it was suggested to us, as the joint organisers, 
that it might be helpful if we produced a survey of 
the main contributions during the Course and in 
particular provided a bibliography that would serve 
as an entrCe to the field. 
It has for long been realised that the polypeptides 
of secretory proteins, in transit from their site of 
synthesis on the ribosomes of the rough surfaced 
endoplasmic reticulum (ER), undergo changes to 
their structure as they pass through the smooth 
surfaced ER and the Golgi Complex. In particular they 
may be modified by phosphorylation and/or glyco- 
sylation and in some cases a peptide may be deleted, 
as in the case of insulin where a single chain protein 
is converted into one with two chains linked by 
disulphide bonds. There is much uncertainty con- 
cerning the precise intracellular site of such activities 
and of the particular enzymes involved. 
Recent research has shown that the modifications 
of secretory proteins may be much more profound 
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than those already indicated. Not only have an 
increasing number of proteins been shown to be 
produced as precursors, which are converted in the 
Golgi Complex, but it is becoming apparent that 
secretory proteins are characterized by their synthesis 
with a characteristic peptide at their N-terminus. This 
idea was originally put forward as a hypothesis by 
Blobel and Sabatini [ 11. They suggested that secretory 
proteins would have a common sequence of amino 
acids near the N-terminus of the nascent chains and 
that the peptide, or a modification of it, would then 
be recognised by a factor mediating the binding to 
the membrane. It was Milstein et al. [2] who pro- 
posed, from experiments in which immunoglobulin 
light chain mRNA was translated in a reticulocyte 
lysate system, that light chains are initially synthesized 
as a precursor of slightly higher molecular weight, 
which is subsequently converted into the authentic 
product. From these experiments they proposed, 
independently of Blobel and Sabatini, that a short 
peptide at the N-terminus of a precursor protein 
would be a simple way to provide a signal to ensure 
that secretory proteins were synthesized on bound 
polysomes. As described later in this review further 
evidence for this hypothesis has been provided, 
particularly by Blobel and from results obtained 
from parathyroid hormone and insulin. 
Much of the current work in this field depends 
on the fact that it is now possible to isolate a mRNA 
for a specific protein and for this to be translated in 
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heterologous cell-free systems. Such an approach also 
leads to an understanding of the subunit size of large 
proteins and has demonstrated, in at least one case, 
that a giant protein is synthesized in one tissue and 
transported to another where it is cleaved into two 
biologically active proteins. 
2. The basic secretory pathway 
The plan of the Course was to describe first what 
may be called the basic secretory pathway (Palade) 
f3] and then to move on to a consideration of 
particular proteins. 
G. Blobel of The Rockefeller Univ., New York 
started the Course by dealing with the initial event 
in the secretory pathway. The so-called ‘Signal 
Hypothesis’ (fig. 1) has been elaborated in his labora- 
tory [4] to provide a scheme for the translation of 
mRNAs for secretory proteins on membrane bound 
ribosomes and the transfer of the translation products 
across the microsomal membrane by the ribosome 
membrane junction. It is proposed that all mRNAs 
for secretory proteins code for a unique peptide - 
the signal peptide - which constitutes a metabolically 
short-lived amino terminal extension present only in 
nascent, incomplete chains. The signal peptide of the 
nascent chain emerging from a space within the large 
ribosomal subunit penetrates into the microsomal 
membrane thereby causing association of several 
ribosome receptor proteins of the ER membrane to 
IGNAL COOONS 
form a proteinaceous tunnel in the membrane. The 
signal peptide induces association of these proteins 
to provide the conditions for a coordinated binding 
of the large ribosomal subunit of the translating 
ribosome to the ER membrane (linking the tunnel in 
the large ribosomal subunit with the newly formed 
tunnel in the membrane) and furthermore permits 
the passage of the signal peptide and continuous 
sequences of the nascent chain through the ER 
membrane into the intracisternal space. The signal 
peptide is removed before the chain is completed 
by a membrane-bound enzyme - referred to as 
‘signalase’. Following release of the nascent chain 
from the ribosome the latter is detached from the 
membrane eliminating the membrane tunnel and 
ready to translate any other mRNAs independent of 
whether the latter do or do not contain ‘signal 
codons’. 
The following evidence for the signal hypothesis 
has been accumulated in his laboratory. They have 
shown [SJ that mRNAs for pancreatic secretory 
proteins are translated in an in vitro protein synthe- 
sizing system (which contains no membranes, that is, 
it contains no ‘signalase’ activity) into precursor 
molecules larger by l-2000 mol. wt than authentic 
secretory proteins. Amino terminal sequence analysis 
revealed that these precursors contain an amino 
terminal extension of 16 amino acid residues with a 
striking sequence homology and consisting of a large 
percentage of hydrophobic residues. Translation of 
mRNAs for secretory proteins in the presence of 
‘RIBOSOME RECEPTOR PROTEIN 
I&l. Blobel’s Signal fjypothesis. A schematic representation of the translation of messenger RNA for secretory proteins on 
membrane bound ribosomes and the transfer of the translation products across the microsoma1 membrane. 
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heterologous ribosome-stripped microsomal mem- 
branes led to ribosome attachment to the membrane, 
transfer of the nascent chain into the intravesicular 
space and removal of the signal peptide from the 
nascent chain. In contrast, globin mRNA (lacking 
signal codons) did not result in ribosome attachment 
or transfer into the intravesicular space [6] - as 
predicted in the signal hypothesis. They have also 
shown that the signal peptide is cleaved from the 
nascent chain before the chain is completed [4]. 
Furthermore a detachment factor has been isolated 
which detaches ribosomal monomers (not containing 
nascent polypeptide chains) from the membrane [7]. 
After an explanation of current views on the sub- 
sequent events in the secretory process by C. R. 
Hopkins (Univ. Liverpool, England), c. Poort (State 
Univ., Utrecht, The Netherlands) described briefly 
some experiments on the intracellular transport of 
puromycyl-peptides in rat pancreas. F. Melchers 
(Base1 Institute for Immunology, Switzerland) then 
considered critically the glycosylation of immuno- 
globulins (Ig). First, however, he described the syn- 
thesis of the surface-membrane-bound form and the 
secreted form of IgM as it occurs in resting and 
stimulated, normal and malignant B-lymphocytes. 
In the surface membrane of B-cells Ig binds 
haptenic determinants of antigens as a part of a 
complex of receptors involved in the regulation of 
growth and differentiation of Ig-secreting cells. 
Stimulation of the small, surface IgM receptor- 
containing B-cells, results in proliferation and matura- 
tion of clones of cells secreting the particular type 
of Ig which served as the receptor molecule on the 
originally triggered cell. One of the earliest changes 
observed in small B-cells after stimulation is the 
induction of active secretion. This reprogramming of 
IgM synthesis, from the synthesis of the membrane- 
bound to the secreted form, occurs also in the absence 
of DNA- and RNA-synthesis and may, therefore, 
initially be regulated at the translational level. During 
growth, after stimulation, B-cells appear to balance, 
within the cell cycle, between reactions leading to 
maturation (secretion) and reactions leading to growth 
(receptor synthesis) [8,9]. The assay for secretion 
depends on a new plaque assay with which all cells 
secreting Ig of a given type or class are detected [lo] . 
He described the addition of carbohydrate to Ig 
as it passes from the polysomes to the rough ER to 
the smooth ER. It seems that, through dolichol phos- 
phate intermediates, the ‘core’ polysaccharides 
containing mostly mannoses and N-acetyl-glucosamines 
are added to the polypeptides in one piece in the 
rough ER. Further lengthening of the carbohydrate 
chains by ‘branch’ monosaccharides, such as galac- 
toses, fucoses and N-glycolyl-neuraminic acids occurs 
in steps in the smooth ER. Concerning the role of 
giycosylation in secretion one must take account of 
the fact that some Ig light chains are produced which 
have no carbohydrate and yet these are satisfactorily 
secreted. Melchers concluded, therefore, that the role 
of glycosylation in the secretion of proteins is 
unknown. 
3. Endocrine Systems 
3.1. Pituitary 
The Course then turned to a discussion of the 
synthesis of specific secretory proteins considering 
first endocrine systems. For the pituitary, M. Wallis 
(Univ. Sussex, England) described current views on 
the biosynthesis of growth hormone (GH) and 
prolactin. 
It was suggested some years ago that CH is 
synthesized as a precursor: this could explain the 
heterogeneity seen at the N-terminus of the bovine 
hormone [ 111. Various studies suggested that high- 
molecular-weight complexes may merely be associa- 
tions of GH with other proteins and/or nucleic acids 
[ 121. Recently Sussman et al. [ 131 have translated 
the mRNA for rat GH in the wheat germ cell-free 
system and demonstrated the existence of a precursor 
of GH (pre-GH) with a mol. wt of about 24 000 
(compared with about 20 000 for rat GH itself). 
Processing of the precursor in the pituitary cell seems 
to be very rapid. The relation between this pre-GH 
and the large-molecular-weight forms of the hormone 
detected previously remains unclear. 
During the last year several groups have provided 
evidence for a biosynthetic precursor of rat prolactin 
(pre-prolactin) [ 14-161. Again, translation of mRNA 
for the hormone in a wheat germ cell-free system has 
been employed. Pre-prolactin has a mol. wt of 
24-28 000, compared to about 22 000 for prolactin 
itself. 
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3.2. Placenta 
B. Peeters from the laboratory of W. Rombauts 
(Catholic Univ. Louvain, Belgium) considered the 
placenta and described the properties of a biologically 
active mRNA from human tissue. This RNA was 
extracted from polysomes, purified by chromatography 
on poly(U)-Sepharose and was shown to contain 6% 
poly(A) and to sediment at about 12 S. It was used to 
investigate radioactive amino acid incorporation after 
injection into oocytes of Xenopus laevis or incubation 
in a cell-free system from wheat or rye germs. Using 
a highly specific and sensitive immunoprecipitation 
reaction human placental lactogen (hPL) was identi- 
fied as one of the total mRNA induced proteins. The 
synthesis of the hormone (3.3%) could still be 
detected after 6 days of incubation of oocytes, while 
in the wheat germ cell-free system hPL accounted 
for 15% as measured by immuno-precipitation. 
Analysis by SDS-gel electrophoresis demon- 
strated that the in vitro synthesized product had the 
same mobility on a 10% gel as a r4C-labelled acetyl- 
ated hPL marker. However recent analysis of the 
products synthesized in the wheat germ cell-free 
system, using a 15% SDS-gel in Tris-glycine buffer, 
allowed a separation of the immunoprecipitate into 
three radioactive bands, one having the same mol. wt 
as the authentic hormone (22 300) and two precursor 
products (24 000-25 100) which were also observed 
by other groups [17-191. The nature of the latter 
products is under investigation. 
3.3. Pancreas 
For the third endocrine system attention turned 
to the pancreas, a historically important source of 
concepts regarding the organization of the secretory 
process. Steiner (Univ. Chicago, USA) described recent 
studies on precursors of islet hormones. Insulin has 
long been known to be formed from a precursor, 
proinsulin, in which the two chains are linked by a 
peptide [20]. The primary structure of the linking 
peptide from many species shows a wide variation 
and it is probably not biologically active [20,21]. 
Many other small peptide hormones are now known 
to be derived from similar larger precursor forms and 
to be processed to their active forms via specific 
intracellular cleavage at sites bearing pairs of basic 
residues [22]. The processing of most pro-proteins 
occurs intracellularly as the newly synthesized 
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secretory product passes near or through the Golgi 
region into condensing vacuoles or newly formed 
secretory granules [20]. In the case of insulin and 
other islet hormones such as glucagon, the cells of 
origin contain only a small percentage of intact 
precursor or intermediate forms, and this is reflected 
in the secretion normally of only very small amounts 
of these materials into the blood stream. However, 
precursor forms may tend to accumulate in the blood 
due to their relatively slow metabolism [23] . The 
kidney often is a major site for their removal from 
the blood; thus high levels of proinsulin and of 9000 
mol. wt glucagon are found in the plasma of patients 
with renal disease [24]. 
Recent work in several aboratories also indicates 
that such pro-proteins may contain more than one 
active sequence, e.g., fl-lipotropin, a 90 residue 
pituitary peptide, contains both /3-MSH and C frag 
ment or /I-endorphin, a peptide having strong opiate 
activity, linked together through a dibasic cleavage 
site [25,26]. Steiner proposed that the major role of 
such precursors may be to overcome length con- 
straints in biosynthesis. Thus, at least 70 residues 
may be required to span the distance from the site 
of synthesis between the ribosomal subunits across 
the membrane to the interior of the cisternae of the 
rough ER. Exceptions to this simple rule are pro- 
albumin and proparathyroid hormone which both 
exceed this minimum size criterion. Interestingly, 
these pro-proteins both have similar highly basic 
hexapeptide extensions at their N-terminal suggesting 
either a role in intracellular transport or in feedback 
control of transcription or translation by the pro- 
peptide. 
Duguid et al. [27] have recently isolated and 
partially characterized the mRNA for insulin and 
Chan et al. [28] have translated this mRNA in a cell- 
free system derived from wheat germ. The mRNA 
was about 9.3 S (mol. wt = 210 000) and had a ‘cap’, 
i.e., methylated 5’-terminus m7G5’ ppp”N [26]. In 
agreement with reports from several aboratories 
[29,30] the product of translation is larger than pro- 
insulin by a mol. wt of about 2-3000. Chan et al. have 
shown that this preproinsulin differs from proinsulin 
in having an N-terminal extension of approximately 
23 amino acids [28]. The pre-peptide sequence is 
particularly rich in hydrophobic residues such as 
leucine, and the distribution of these is similar but 
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not identical in comparing the bovine and rat 
preproinsulins [Chan, Lomedico and Steiner, 
unpublished data]. 
S. Howell (Univ. Sussex, England) described recent 
work on the intracellular storage of insulin. Following 
its biosynthesis in the rough surfaced ER, proinsulin 
is transported to the Golgi Complex in membrane- 
limited vesicles by an energy dependent process 
[3 1,321. Enzymic conversion of proinsulin to insulin 
is initiated in the Golgi Complex and completed 
during formation of the storage granules. The mature 
granules are known to contain an electron-opaque 
core which may be composed of insulin in a crystalline 
form, and in addition zinc (in some species), connect- 
ing peptide, and biogenic amines [32]. Preliminary 
electron microscope X-ray micro-analyses of the ion 
content of the granules in frozen sections show the 
presence of sodium, phosphorus, sulphur, chlorine, 
potassium and calcium. This calcium content appears 
to be relatively stable and, unlike the labile mito- 
chondrial pool of this ion, seems unlikely to be 
involved in the minute by minute regulation of rates 
of insulin secretion [33]. 
The aim of their work has been to characterize 
the true thyroglobulin precursor(s) from the heterolo- 
gous translation of its (their) mRNA(s). The results 
may be summarised as follows: 
(1) Thyroglobulin is synthesized on a population 
of very large (> 50) membrane bound polysomes. 
(2) These polysomes contain a poly(A)-rich RNA 
of sedimentation coefficient about 33 S. 
(3) The 33 S poly(A)-RNA is translated in the 
Xerzopus oocyte to give a 300 000 mol. wt peptide 
immunologically related to thyroglobulin. 
(4) No RNA of other size could promote the 
synthesis of immuno-reactive thyroglobulin. 
(5) The 300 000 mol. wt peptide polymerizes 
spontaneously into 19 S thyroglobulin. 
(6) Tryptic peptide analysis reveals chemical 
identity between the 300 000 mol. wt peptide and 
authentic 19 S thyroglobulin. 
3.4. Thyroid 
From these results, Vassart concluded that thyro- 
globulin is synthesized from the translation of a 33 S 
mRNA into two 300 000 mol. wt subunits. All 
subunits of other size would thus originate from 
post-translational cleavages of this precursor. An 
influence of iodination on these cleavages is suggested 
but remains to be demonstrated [34,35]. 
The thyroid gland was the next endocrine system A somewhat contrary view was taken by Ph. de 
considered. G. Vassart (Univ. Libre de Bruxelles, Nayer (ICP, Univ. Louvain, Belgium). He described 
Belgium), spoke about the synthesis and degradation experiments in which bovine thyroid RNA species 
of thyroglobulin. Thyroglobulin is the major product were separated by cellulose chromatography and/or 
of thyroid protein synthesis. It represents both a by sucrose density gradient ultracentrifugation. 
precursor and a storage form of the thyroid hormones. Identification of mRNA was performed by incubating 
The number and the size of the protomers of this ahquots of RNA thus fractionated in a cell-free 
huge protein (mol. wt 660 000, sedimentation system of Krebs II ascites cell lysate. Stimulation of 
coefficient 19 S) has been the matter of a long-lasting specific protein synthesis was obtained with RNA 
controversy. Molecular weights ranging from fractions with approximate S-values of 40,30,24 and 
20-200 000 have been reported. Recently, it has 16. Experiments were performed to characterize 
been suggested that contamination of thyroglobulin these mRNAs, and determine their mol. wt. This was 
preparations by proteolytic enzymes could explain done using gel electrophoresis of RNA isolated from 
in part these discrepancies. However, even in proteo- thyroid slices previously incubated with the labelled 
lytic-free thyroglobulin at least three kinds of subunits precursors, [3H]uridine or [3H]adenosine. In total 
have been isolated (mol. wt 300 000, 200 000, RNA, as well as in poly(A) rich RNA samples, the 
100 000) the relative proportion of which is related radioactivity was located in 4 bands. The electro- 
to the iodine content of the molecule. These results phoretic mobility of these bands corresponded to 
could be explained either by iodine related post- the mobility of RNA molecules with an apparent 
translational cleavages of a unique 300 000 mol. wt mol. wt of 3.1 X 106, 2.2 X 106, 1.2 X lo6 and 
precursor, or by the existence of three different 0.6 X 1 06. The 3 largest RNA could contain the 
subunits, the synthesis of which would be regulated information for peptides of about 3 X 10’) 
by the availability of iodine. 2 X IO5 and 1 X 10’ mol. wt. The estimates of the 
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encoded proteins are close to the values recently 
reported by Haeberli et al. [36] for the 3 polypeptide 
chains of guinea-pig thyroglobulin. 
The presence of several mRNA species raises the 
question of a possible regulatory role of these mRNAs 
in thyroglobulin synthesis and assembly. In this 
regard it is interesting to mention preliminary 
observations indicating that the addition of TRH or 
KI (1 0e6 M) to the cell cultures alters the distribu- 
tion of the radioactivity among the 4 bands of 
RNA [37]. 
3.5. Parathyroid 
Attention then turned to the parathyroid gland 
and J. F. Habener and J. T. Potts, Jr. (both of Mass. 
General Hospital, Boston, USA) described their work 
on parathyroid hormone (PTH). Studies of PTH 
biosynthesis in vitro indicate that the predominant 
cellular hormonal product, PTH, a single-chain poly- 
peptide of 84 amino acids, arises from a larger 
precursor via two successive proteolytic cleavages: 
Pre-ProPTH( 115 aa’s) - ‘12 fl% ProPTH 
15 min 
(90 aa’s) - - - + PTH (84 aa’s). 
Pre-Proparathyroid hormone (Pre-ProPTH) is the 
major protein synthesized by translation of para- 
thyroid mRNA in a cell-free system derived from 
wheat germ and appears to be the initial protein 
coded for by the gene for PTH. Analysis by a sensitive, 
micro-sequencing procedure of the amino acid 
sequence of radioactive Pre-ProPTH from the wheat 
germ system gives the following structure: 
I Pre-ProPTH 
HZN-met-met-ser-ala-lys-asp-met-val-lys-val-met-ile- 
Pre-ProPTH-F 
val-met-leu-ala-ile-X-X-leu-ala-arg-ser-asp-gly----- 
ProPTH-> --pTH--7 
--------lys-ser-val-lys-lys-arg-ala---------gln-C~H. 
Appropriate identification of each radioactive 
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amino acid at its known position within the sequence 
of ProPTH was used as a criterion for the correct 
identification of the amino acid in the sequence of 
Pre-ProPTH. The N-terminal methionine is incorpo- 
rated into Pre-ProPTH selectively by initiator 
methionyl tRNA. The C-terminal tryptic tetrapeptides 
of Pre-ProPTH, ProPTH and PTH are identical when 
analysed by two-dimensional chromatoelectropho- 
resis. Translation of parathyroid mRNA in a Krebs 
ascites cell-free system containing reticular membranes 
reveals that the major product synthesized is ProPTH 
and that a substantial fraction of the Pre-ProPTH 
synthesized lacks both N-terminal methionines. 
Kinetics pulse and pulse-chase labelling studies using 
intact slices of parathyroid glands show that small 
amounts of radioactive Pre-ProPTH are detectable 
and reach a maximum within 2 min, ProPTH appears 
by 1 min and PTH does not appear until 15 min. 
The data in toto suggest a role for the precursors 
in the sequential segregation and translocation of the 
hormonal polypeptides within subcellular organelles. 
They propose that the hydrophobic ‘pre’ sequence is 
a ‘signal sequence’. The delay of 15 min, before 
tryptic-like proteolytic conversion of ProPTH to PTH 
occurs, corresponds to the time required for the 
transport of the newly-synthesized polypeptide to the 
Golgi Complex and suggests that the ‘pro’ sequence 
may be involved in the transport of the prohormone 
within the cisternal space (from RER to Golgi) 
[ 38-401. 
Potts described the problems of microsequencing 
of the amino acids in the signal peptide. It is of course 
only possible to determine the primary structure of 
these peptides by the use of radioactive amino acids 
during their biosynthesis in a cell-free system; conven- 
tional techniques for sequence analysis cannot be used 
because only picogram quantities of precursor 
peptide are present in tissues. Under good conditions 
and by careful interpretation of the results the method 
is capable of providing an analysis which is as satis- 
factory as the more macro methods [41] . 
4. Exocrine Systems 
4.1. Mammary gland 
From the endocrine systems the Course moved to 
an exocrine organ, namely the mammary gland and 
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P. N. Campbell (Courtauld Institute, London, 
England) spoke of the biosynthesis and secretion of 
milk proteins. 
The bulk of the proteins in the milk are synthesized 
in the mammary gland under hormonal control. The 
milk proteins, synthesized in the gland, can be sepa- 
rated into caseins and the whey protein cu-lactalbumin 
(a-LA). In addition, the whey of ruminants contains 
a further protein /3-lactoglobulin (p-LG). o-LA plays a 
role in the synthesis of lactose and interacts with 
galactosyl-transferase which is a marker enzyme in the 
Golgi Complex [42]. There are three main groups at 
present studying the biosynthesis of milk proteins. 
Rosen at Baylor, Houston, uses rats, Houdebine and 
Gaye at the C.N.R.S., France, use ewes and rabbits 
and Campbell and Craig at the Courtauld Institute, 
London, use guinea-pigs. 
In guinea-pigs it has been shown that for (r-LA the 
primary translation product is a precursor with 7-10 
additional amino acids at the N-terminus [43]. Other 
groups have not so far detected a similar precursor in 
their systems. 
For casein no-one has yet conclusively demon- 
strated that the various proteins are synthesized in the 
form of a precursor with an N-terminal extension. 
When mRNAs from lactating mammary glands of 
either rat or guinea-pig were translated in wheat germ 
or ascites tumour cell systems and the products iso- 
lated by a double antibody technique were run on 
SDS-polyacrylamide gels then the synthesized 
products had a slightly higher mobility than the 
authentic caseins from milk. In view of the fact that 
caseins are glycosylated and phosphorylated and 
these modifications may influence their behaviour 
in gels it remains possible that a slightly larger casein 
precursor will yet be detected. No such precursor has 
been found in extracts from ewe mammary glands 
[44]. There is also a possibility that the final caseins 
are derived from a single macro-molecule since the 
mRNAs are larger than predicted. 
mRNA for milk protein may be isolated from the 
polysomes of lactating glands in all the species pre- 
viously mentioned [45]. If membrane-bound and 
free polysomes are isolated from ewe mammary 
glands then Gaye and Denamur [46] showed that the 
bound polysomes were the site of synthesis of /.%LG. 
They have claimed an absence of mRNA for casein 
in free polysomes from the same tissue. Harrison et al. 
[47] have shown that both the bound and free 
polysomes in lactating glands from guinea-pig possess 
mRNA for casein. This would be in accord with the 
signal hypothesis as presumably chain initiation must 
involve free polysomes. 
4.2. Bee- Venom 
G. Kreil (Institute of Molecular Biology, Salzburg, 
Austria) reminded the Course that interesting studies 
can be done with eukaryotes other than mammals 
and he described work on the biosynthesis of melittin 
in the honeybee. Melittin, a peptide comprised of 
26 amino acids, is the main constituent of honeybee 
venom. This venom is produced by a Y-shaped, 
tubular gland located in the abdomen of the insect. 
After feeding labelled amino acids to bees, a radio- 
active precursor of melittin could be detected in this 
gland. This precursor, called promelittin, contains 
8-9 extra residues at the N-terminus [48]. In worker 
bees, venom production starts only slowly after the 
emergence of the insect. In contrast the venom gland 
of queen bees operates at full capacity at emergence 
1491. 
From venom glands of young queen bees, the 
mRNA for promelittin has been isolated and charac- 
terized [50]. Injection of this mRNA into frog 
oocytes leads to the formation of a product closely 
resembling promelittin [51]. In contrast, translation 
of this mRNA in cell-free systems, derived from 
mammalian cells [52] or from wheat germ, yields a 
larger product which has been called protomelittin 
and which can now, in accordance with similar 
precursors, be termed pre-promelittin. Structural 
investigations of this substance gave the following 
results: 
(1) At the C-terminus it contains an extra glycine 
residue; while the venom components terminate 
with gln-amide, pre-promelittin has a C-terminal 
gln-glyCOOH sequence. 
(2) At the N-terminus, pre-promelittin starts with 
a sequence of at least 33 residues, of which about the 
first 20 are largely hydrophobic. This part contains 
tyr, phe and met residues which are not present in 
promelittin. 
The biosynthesis of the toxic peptide melittin thus 
involves at least three posttranslational reactions: 
(1) Conversion of pre-promelittin to promelittin; 
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(2) formation of the correct C-terminal amide with 
concomitant loss of one glycine residue; 
(3) activation of promelittin to melittin. 
5. Fibroblasts and the synthesis of collagen 
The synthesis of collagen by the fibroblasts is 
probably the major protein synthetic activity of the 
body in early life in terms of quantitative output. 
M. E. Grant (Univ. Manchester, England) described 
work on the biosynthesis of collagen. In all the 
mammalian tissues studied collagen molecules seem to 
be essentially the same in that they are semi-rigid, 
rod-shaped molecules comprising three polypeptides 
(CX chains) in a triple-helical conformation. Recent 
studies indicate, however, that from tissue to tissue, 
and even within the same tissue, collagen molecules 
can differ in their primary structure and at least four 
genetically distinct types (I-IV) are known. All four 
types are synthesized in precursor forms, procollagens, 
comprising poly-peptides (pro-o chains) which are 
approx. 50% of non-helical peptide extensions at 
both the amino- and carboxyl-terminal ends [53]. 
The amino acid sequence coded by procollagen 
mRNA must undergo at least 7 post-translational 
enzymic modifications before the protein is functional 
in the extracellular space. Considerable advances have 
been made in our understanding of these unique 
processes which include hydroxylation of prolyl and 
lysyl residues [.54], glycosylation of hydroxylysyl 
residues [ 551, scission of the extension peptides [ 561 
and eventual stabilisation of the extracellular fibrils 
by intermolecular cross-links [ 571. The significance 
of these enzymic events and the role of the extension 
peptides in the assembly and secretion of the pro- 
collagen molecule was discussed (see also [ 581). 
There followed a talk by R. Harwood (Univ. 
Wales, Cardiff) on the role of free and membrane- 
bound ribosomes in the biosynthesis of procollagen 
[ 58,591. 
6. The hepatocyte 
6.1. Vitellogenin 
On the final morning the Course turned to the 
hepatocyte and considered two proteins synthesized 
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in the liver, namely vitellogenin and serum albumin. 
Vitellogenin is particularly interesting since here we 
have a precursor protein that is subsequently cleaved 
into two biologically active proteins in an organ other 
than that in which it was synthesized. M. Gruber 
(Univ. Groningen, The Netherlands) described progress 
in our understanding of this interesting phenomenon, 
particularly in the chick which is the system he has 
studied. 
The yolk of oviparous vertebrates, like birds, 
contains two yolk-specific proteins, lipovitellin and 
phosvitin which together form the majority of the 
mass of yolk proteins. Phosvitin is a phosphoprotein 
with the highest phosphorus content of all known 
phosphoproteins (10% P) - it also contains some 
carbohydrate. Lipovitellin contains some phosphate 
groups. The two proteins are deposited in yolk in a 
one to one molar ratio of the subunit peptide chain 
(chicken lipovitellin peptide chain about 135 000 
mol. wt phosvitin peptide chain about 25 000 mol. wt). 
The liver is the origin of these two proteins. Phos- 
vitin and lipovitellin are not synthesized separately, but 
as parts of one large molecule, vitellogenin. Vitello- 
genin is secreted by the liver and split into phosvitin 
and lipovitellin in the course of, or after, uptake by 
the ovary. Consequently, phosvitin and lipovitellin 
are present in the yolk granules in a molecular ratio 
of one to one. 
The existence of vitellogenin was only recently 
discovered because it is very susceptible to traces of 
proteolytic enzymes. The vitellogenin peptide chain 
of more than 1500 amino acids is synthesized in the 
chicken liver on large polysomes (consisting of 
30-40 ribosomes) which are,bound to the membranes 
of the ER. This synthesis requires less than 4 min; the 
finished protein is secreted only lo- 15 min after 
completion of translation. Phosphorylation is a late 
event occurring within the last 5-6 min before 
secretion [60-631. 
The Groningen group has isolated the mRNA for 
chicken vitellogenin. Its translation in a heterologous 
cell-free system gives rise to a protein with a slightly 
higher mobility on SDS-polyacrylamide gels than the 
authentic protein. This higher mobility is probably 
due to the lack of phosphorylation (and glycosyla- 
tion) of the in vitro product, a situation comparable 
to casein, mentioned above. A small signal peptide 
in the in vitro product will thus not be reflected by 
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mobility in SDS. Translation of chicken vitellogenin 
mRNA in Xenopus oocytes leads to a product 
apparently identical with the chicken plasma vitello- 
genin. The oocyte thus also phosphorylates chicken 
vitellogenin. Probably, glycosylation occurs, too. 
S. R. Farmer (N.I.M.R., London, England) briefly 
described some of his experiments on the primary 
and secondary induction of response to oestrogen in 
Xenopus liver in vivo [64] . 
A quite different system which involves the control 
of hormones on ovarian development in mosquitoes 
was then described by M. S. Fuchs (Univ. Notre Dame, 
Indiana, USA). 
After adult eclosion, oocyte maturation in the 
anautogenous mosquito Aedes aegypti is characterized 
by a previtellogenic period during which slight growth 
and differentiation occurs. Further development 
ceases after about 48 h and at this time the ovary has 
reached its resting-stage. Such resting-stage ovaries 
will remain in this arrested condition indefinitely if 
the adult female is not allowed to blood-feed. New 
development leading to oocyte maturity proceeds only 
after blood engorgement whereupon yolk synthesis 
and its subsequent deposition ensues. 
Females deprived of juvenile hormone (JH), 
shortly after eclosion (by allatectomizing them), do 
not exhibit resting stage ovaries and moreover 
apparently do not synthesize yolk protein [65]. 
Vitellogenesis in A. aegypti is normally regulated 
by the steroid moulting hormone (BH), which is 
produced by the ovary after blood-feeding. The 
major yolk proteins in many insects, including 
A. aegvpti, are synthesized by the fat body and are 
transported via the haemolymph to the ovary. It is 
now clear that a primary function of MH (specifically 
fl-ecdysone) in this species is to activate the fat body 
to synthesize these yolk proteins [66,67]. 
It has been postulated that blood-feeding results 
in the release of a ‘brain hormone’ which in turn is 
steroidiogenic with respect to the ovary. Thus, in 
mosquitoes a cycle is envisaged which is remarkably 
similar, both anatomically and biochemically, to the 
pituitary-ovary-liver-ovary cycle found in many 
vertebrates. 
With regard to the action of JH and MH in yolk 
protein synthesis by the fat body, his evidence was 
consistent with the view that MH induces specific 
mRNA synthesis and MH then modulates the transla- 
tion of these pre-formed messengers [68-701. 
6.2. Serum albumin 
J. D. Judah (Univ. College Hosp. Med. Sch., 
London, England) described current work on the 
biosynthesis of serum albumin in rat liver. Antibodies 
to rat serum albumin recognize at least two species 
when applied to detergent extracts of rat liver. One 
of them is more basic than serum albumin and the 
other is serum albumin itself. The proteins can easily 
be separated from each other by electrofocusing on 
pH gradients or by ion-exchange chromatography, 
but not by gel filtration. The basic component 
accounts for approximately 90% of the label in the 
antibody precipitate after a pulse of labelled amino 
acid, both in vivo and in vitro. It has been identified 
as a proalbumin, which is converted to serum albumin 
by limited proteolysis by trypsin or by cathepsin B. 
Proalbumin contains a hexapeptide with the sequence 
arg-gly-val-phe-arg-arg- attached to the N-terminal 
glu of rat serum albumin. 
Kinetic experiments and balance studies provide 
firm evidence that proalbumin is the source of 
secreted serum albumin. If cycloheximide is used to 
block protein synthesis in vivo or in perfused livers, 
the proalbumin levels fall to account exactly both in 
rate and amount for the albumin exported. 
Microtubule poisons such as colchicine inhibit the 
secretion of albumin. The rate of conversion of 
proalbumin in the liver is reduced to the same extent. 
No accumulation of proalbumin is seen, since the rate 
of biosynthesis falls to accommodate the diminished 
rates of conversion and secretion. [71-771. 
7. Concluding remarks 
In summarizing the main points of the meeting 
J. R. Tata (N.I.M.R., London, England) drew atten- 
tion to the following. 
(1) The concepts of the role of the organelles in the 
synthesis and secretion of proteins are based 
soundly on the early work of Palade [3] and his 
group at The Rockefeller University. 
(2) There are many important enzymes associated 
with the ER. Not only does glycosylation and 
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phosphorylation take place on the membranes but 
pro-proteins have to be converted to the final 
product and now we realise that signal peptides 
have to be removed in the conversion of pre-pro- 
proteins to pro-proteins. 
(3) There are some interesting similarities between 
the pro-peptides of albumin and parathyroid 
hormone but this does not lead to a conclusion 
concerning their function. The signal peptides 
appear to be rich in hydrophobic amino acid 
residues and their primary sequence is rapidly 
being determined. The work of Burstein et al. on 
the peptides of the light chain of IgG is particu- 
larly relevant and it is interesting that the signal 
peptides of the various light chains differ in 
structure [78,79]. 
(4) The signal hypothesis as formulated by Blobel 
has helped to clarify the work now being done 
on the biosynthesis of many different proteins. 
Although the development of mixed heterologous 
systems have helped to test the validity of the 
hypothesis many details remain to be proven. 
(5) The recently published modification of the reticulo- 
cyte lysate system described by Pelham and 
Jackson [80], in which the endogenous mRNA is 
removed by ribonuclease, should provide a power- 
ful new technique. 
(6) There is great merit in studying as many different 
systems for the synthesis of specific proteins as 
possible. These various systems allow one to focus 
attention on the particular requirements of 
different cells, such as the need for thyroglobulin 
to conserve iodine. In the case of vitellogenin 
there is the opportunity to study reversible induc- 
tion of protein synthesis. 
(7) It is obvious that as yet we know little about the 
precise enzymology of glycosylation and other 
conversions although in this respect the role of 
dolichol phosphate adds a fascinating new 
dimension. 
(8) Future work will no doubt centre on the need 
for polysome-membrane interaction in order to 
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effect the removal of the signal peptide, and to 
the extent which the biosynthesis of intracellular 
proteins really differs from that of secretory 
proteins. Thus many non-secretory cells possess 
membrane bound ribosomes and it certainly 
remains possible that the proteins of the mem- 
branous organelles of the cell, which are made in 
the cytoplasm, are first made on the ribosomes 
bound to the ER as are secretory proteins. 
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